BNP Paribas Financial Markets’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Buy |
176,152
+166,224
| +1,674% | +$15.7M | 0.01% | 860 |
|
|
2025
Q1 | $630K | Sell |
9,928
-5,812
| -37% | -$369K | ﹤0.01% | 2268 |
|
|
2024
Q4 | $731K | Sell |
15,740
-44,471
| -74% | -$2.07M | ﹤0.01% | 2264 |
|
|
2024
Q3 | $1.73M | Buy |
60,211
+38,434
| +176% | +$1.11M | ﹤0.01% | 1497 |
|
|
2024
Q2 | $315K | Sell |
21,777
-1,635
| -7% | -$23.6K | ﹤0.01% | 2238 |
|
|
2024
Q1 | $377K | Buy |
23,412
+21,384
| +1,054% | +$344K | ﹤0.01% | 2347 |
|
|
2023
Q4 | $40.3K | Buy |
2,028
+1,128
| +125% | +$22.4K | ﹤0.01% | 2884 |
|
|
2023
Q3 | $14.7K | Sell |
900
-13,860
| -94% | -$226K | ﹤0.01% | 2913 |
|
|
2023
Q2 | $312K | Buy |
14,760
+3,778
| +34% | +$79.9K | ﹤0.01% | 2227 |
|
|
2023
Q1 | $221K | Buy |
10,982
+10,560
| +2,502% | +$212K | ﹤0.01% | 2491 |
|
|
2022
Q4 | $11K | Buy |
+422
| New | +$11K | ﹤0.01% | 2944 |
|
|
2022
Q1 | – | Sell |
-238
| Closed | -$1.6K | – | 3672 |
|
|
2021
Q4 | $1.6K | Buy |
+238
| New | +$1.6K | ﹤0.01% | 3367 |
|